BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7562575)

  • 1. Microinfusion of mu but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats.
    Helmstetter FJ; Bellgowan PS; Poore LH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):381-8. PubMed ID: 7562575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
    Shin MS; Helmstetter FJ
    Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
    Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians.
    Stevens CW
    J Pharmacol Exp Ther; 1996 Feb; 276(2):440-8. PubMed ID: 8632308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
    Zhou L; Zhang Q; Stein C; Schäfer M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.